Jodi A Condra1, Holly Neibergs, Wei Wei, Mark D Brennan. 1. Department of Biochemistry and Molecular Biology, Center for Genetics and Molecular Medicine, University of Louisville School of Medicine, Louisville, KY 40292, USA.
Abstract
OBJECTIVE: Previous linkage scans and meta-analyses for schizophrenia susceptibility loci failed to include the most distal portion of chromosome 22q. Accordingly, 27 families having individuals affected with schizophrenia and schizophrenia-spectrum disorders were analyzed using a set of highly informative markers covering all of chromosome 22q. METHODS: Microsatellite and single nucleotide polymorphism markers were evaluated by nonparametric linkage, parametric linkage, and transmission disequilibrium testing of 22q. RESULTS: The maximum nonparametric logarithm of odd scores were 2.9 (P=0.0016) for schizophrenia and 2.7 (P=0.003) for a broader disease definition that included schizotypal personality disorder-both at 44.5 cM within the Sult4A1 locus. Parametric models assuming dominant modes of inheritance and genetic heterogeneity gave maximum multipoint logarithm of odd scores for the broader disease definition at the Sult4A1 locus of 3.3 (P=0.0006) and single point logarithm of odd scores of 3.1-4.8 for Sult4A1 markers (P=0.000015-0.0005). A distal locus, centered at 61 cM, shows a maximum nonparametric logarithm of odd scores of 1.5 (P=0.072) for the broader disease definition. Transmission disequilibrium testing for three adjacent microsatellite markers located near the distal linkage peak revealed significant values for marker D22s526 for schizophrenia (P=0.0016-0.14) and for broader disease definitions including schizotypal personality disorder (P=0.0002-0.0003), and both schizotypal personality disorder plus schizoaffective disorder (P=0.00001-0.000077). CONCLUSION: At least two separable, but closely linked, loci within 22q13 influencing susceptibility to schizophrenia-spectrum disorders, might be possible.
OBJECTIVE: Previous linkage scans and meta-analyses for schizophrenia susceptibility loci failed to include the most distal portion of chromosome 22q. Accordingly, 27 families having individuals affected with schizophrenia and schizophrenia-spectrum disorders were analyzed using a set of highly informative markers covering all of chromosome 22q. METHODS: Microsatellite and single nucleotide polymorphism markers were evaluated by nonparametric linkage, parametric linkage, and transmission disequilibrium testing of 22q. RESULTS: The maximum nonparametric logarithm of odd scores were 2.9 (P=0.0016) for schizophrenia and 2.7 (P=0.003) for a broader disease definition that included schizotypal personality disorder-both at 44.5 cM within the Sult4A1 locus. Parametric models assuming dominant modes of inheritance and genetic heterogeneity gave maximum multipoint logarithm of odd scores for the broader disease definition at the Sult4A1 locus of 3.3 (P=0.0006) and single point logarithm of odd scores of 3.1-4.8 for Sult4A1 markers (P=0.000015-0.0005). A distal locus, centered at 61 cM, shows a maximum nonparametric logarithm of odd scores of 1.5 (P=0.072) for the broader disease definition. Transmission disequilibrium testing for three adjacent microsatellite markers located near the distal linkage peak revealed significant values for marker D22s526 for schizophrenia (P=0.0016-0.14) and for broader disease definitions including schizotypal personality disorder (P=0.0002-0.0003), and both schizotypal personality disorder plus schizoaffective disorder (P=0.00001-0.000077). CONCLUSION: At least two separable, but closely linked, loci within 22q13 influencing susceptibility to schizophrenia-spectrum disorders, might be possible.
Authors: M Ali Bangash; Joo Min Park; Tatiana Melnikova; Dehua Wang; Soo Kyeong Jeon; Deidre Lee; Sbaa Syeda; Juno Kim; Mehreen Kouser; Joshua Schwartz; Yiyuan Cui; Xia Zhao; Haley E Speed; Sara E Kee; Jian Cheng Tu; Jia-Hua Hu; Ronald S Petralia; David J Linden; Craig M Powell; Alena Savonenko; Bo Xiao; Paul F Worley Journal: Cell Date: 2011-05-12 Impact factor: 41.582
Authors: Julie Gauthier; Nathalie Champagne; Ronald G Lafrenière; Lan Xiong; Dan Spiegelman; Edna Brustein; Mathieu Lapointe; Huashan Peng; Mélanie Côté; Anne Noreau; Fadi F Hamdan; Anjené M Addington; Judith L Rapoport; Lynn E Delisi; Marie-Odile Krebs; Ridha Joober; Ferid Fathalli; Fayçal Mouaffak; Ali P Haghighi; Christian Néri; Marie-Pierre Dubé; Mark E Samuels; Claude Marineau; Eric A Stone; Philip Awadalla; Philip A Barker; Salvatore Carbonetto; Pierre Drapeau; Guy A Rouleau Journal: Proc Natl Acad Sci U S A Date: 2010-04-12 Impact factor: 11.205
Authors: Leonhard Lennertz; Michael Wagner; Wolfgang Wölwer; Anna Schuhmacher; Ingo Frommann; Julia Berning; Svenja Schulze-Rauschenbach; Martin W Landsberg; Anja Steinbrecher; Michael Alexander; Petra E Franke; Ralf Pukrop; Stephan Ruhrmann; Andreas Bechdolf; Wolfgang Gaebel; Joachim Klosterkötter; Heinz Häfner; Wolfgang Maier; Rainald Mössner Journal: Eur Arch Psychiatry Clin Neurosci Date: 2011-09-07 Impact factor: 5.270
Authors: Timothy L Ramsey; Herbert Y Meltzer; Guy N Brock; Bharat Mehrotra; Karu Jayathilake; William V Bobo; Mark D Brennan Journal: Pharmacogenomics Date: 2011-04 Impact factor: 2.533
Authors: Daniel Nolan; William E Kraus; Elizabeth Hauser; Yi-Ju Li; Dana K Thompson; Jessica Johnson; Hsiang-Cheng Chen; Sarah Nelson; Carol Haynes; Simon G Gregory; Virginia B Kraus; Svati H Shah Journal: PLoS One Date: 2013-08-02 Impact factor: 3.240